View ValuationCLIO CosmeticsLtd 향후 성장Future 기준 점검 1/6CLIO CosmeticsLtd (는) 각각 연간 10.9% 및 3.3% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 10.4% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 8% 로 예상됩니다.핵심 정보10.9%이익 성장률10.44%EPS 성장률Personal Products 이익 성장30.0%매출 성장률3.3%향후 자기자본이익률8.02%애널리스트 커버리지Low마지막 업데이트06 Jun 2026최근 향후 성장 업데이트Major Estimate Revision • Jun 08Consensus EPS estimates increase by 13%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from ₩322.0m to ₩328.0m. EPS estimate increased from ₩920 to ₩1,040 per share. Net income forecast to grow 8.5% next year vs 38% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩13,000 to ₩12,000. Share price fell 7.8% to ₩10,060 over the past week.Price Target Changed • May 29Price target decreased by 7.1% to ₩13,000Down from ₩14,000, the current price target is an average from 2 analysts. New target price is 13% above last closing price of ₩11,540. Stock is down 27% over the past year. The company is forecast to post earnings per share of ₩920 for next year compared to ₩774 last year.Major Estimate Revision • May 17Consensus EPS estimates fall by 19%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩384.0m to ₩359.0m. EPS estimate also fell from ₩1,826 per share to ₩1,486 per share. Net income forecast to shrink 4.9% next year vs 34% growth forecast for Personal Products industry in South Korea . Consensus price target down from ₩28,750 to ₩23,800. Share price fell 19% to ₩15,450 over the past week.Major Estimate Revision • Feb 26Consensus EPS estimates fall by 16%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩417.1m to ₩384.0m. EPS estimate also fell from ₩2,165 per share to ₩1,826 per share. Net income forecast to shrink 0.2% next year vs 32% growth forecast for Personal Products industry in South Korea . Consensus price target down from ₩34,250 to ₩28,750. Share price fell 9.8% to ₩17,740 over the past week.Price Target Changed • Nov 13Price target decreased by 13% to ₩39,286Down from ₩45,143, the current price target is an average from 7 analysts. New target price is 125% above last closing price of ₩17,480. Stock is down 43% over the past year. The company is forecast to post earnings per share of ₩1,585 for next year compared to ₩1,582 last year.Price Target Changed • Feb 19Price target increased by 7.2% to ₩42,000Up from ₩39,167, the current price target is an average from 6 analysts. New target price is 38% above last closing price of ₩30,400. Stock is up 74% over the past year. The company is forecast to post earnings per share of ₩1,466 for next year compared to ₩584 last year.모든 업데이트 보기Recent updatesMajor Estimate Revision • Jun 08Consensus EPS estimates increase by 13%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from ₩322.0m to ₩328.0m. EPS estimate increased from ₩920 to ₩1,040 per share. Net income forecast to grow 8.5% next year vs 38% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩13,000 to ₩12,000. Share price fell 7.8% to ₩10,060 over the past week.Price Target Changed • May 29Price target decreased by 7.1% to ₩13,000Down from ₩14,000, the current price target is an average from 2 analysts. New target price is 13% above last closing price of ₩11,540. Stock is down 27% over the past year. The company is forecast to post earnings per share of ₩920 for next year compared to ₩774 last year.공시 • May 07CLIO Cosmetics Co.,Ltd to Report Q1, 2026 Results on May 11, 2026CLIO Cosmetics Co.,Ltd announced that they will report Q1, 2026 results on May 11, 2026분석 기사 • Apr 03CLIO CosmeticsLtd's (KOSDAQ:237880) Conservative Accounting Might Explain Soft EarningsShareholders appeared unconcerned with CLIO Cosmetics Co.,Ltd's ( KOSDAQ:237880 ) lackluster earnings report last week...공시 • Mar 14CLIO Cosmetics Co.,Ltd, Annual General Meeting, Mar 31, 2026CLIO Cosmetics Co.,Ltd, Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 66, wangsimni-ro, seongdong-gu, seoul South KoreaValuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩11,170, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total loss to shareholders of 38% over the past three years.공시 • Feb 13CLIO Cosmetics Co.,Ltd to Report Fiscal Year 2025 Results on Feb 13, 2026CLIO Cosmetics Co.,Ltd announced that they will report fiscal year 2025 results on Feb 13, 2026공시 • Jan 07CLIO Cosmetics Co.,Ltd announced that it has received KRW 8.42292238 billion in funding from NH Investment & Securities Co., Ltd., KB Securities Co., Ltd., Mirae Asset Securities Co., Ltd., Samsung Securities Co.,Ltd., Synergy IB Investment Co., Ltd., Synergy-Premier Mezzanine Blind No. 1 New Technology Business Investment Fund and other investorsOn January 7, 2026, CLIO Cosmetics Co.,Ltd closed the transaction.공시 • Aug 09CLIO Cosmetics Co.,Ltd to Report First Half, 2025 Results on Aug 13, 2025CLIO Cosmetics Co.,Ltd announced that they will report first half, 2025 results on Aug 13, 2025New Risk • May 23New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.0% Last year net profit margin: 9.2% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (6.0% net profit margin).Major Estimate Revision • May 17Consensus EPS estimates fall by 19%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩384.0m to ₩359.0m. EPS estimate also fell from ₩1,826 per share to ₩1,486 per share. Net income forecast to shrink 4.9% next year vs 34% growth forecast for Personal Products industry in South Korea . Consensus price target down from ₩28,750 to ₩23,800. Share price fell 19% to ₩15,450 over the past week.Valuation Update With 7 Day Price Move • May 15Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₩16,080, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 13x in the Personal Products industry in South Korea. Total loss to shareholders of 1.6% over the past three years.분석 기사 • Apr 10Pinning Down CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) P/E Is Difficult Right NowWith a median price-to-earnings (or "P/E") ratio of close to 11x in Korea, you could be forgiven for feeling...공시 • Mar 12CLIO Cosmetics Co.,Ltd, Annual General Meeting, Mar 28, 2025CLIO Cosmetics Co.,Ltd, Annual General Meeting, Mar 28, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 66, wangsimni-ro, seongdong-gu, seoul South Korea분석 기사 • Mar 11We Like These Underlying Return On Capital Trends At CLIO CosmeticsLtd (KOSDAQ:237880)Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...Valuation Update With 7 Day Price Move • Mar 11Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₩21,100, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total returns to shareholders of 1.6% over the past three years.Major Estimate Revision • Feb 26Consensus EPS estimates fall by 16%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩417.1m to ₩384.0m. EPS estimate also fell from ₩2,165 per share to ₩1,826 per share. Net income forecast to shrink 0.2% next year vs 32% growth forecast for Personal Products industry in South Korea . Consensus price target down from ₩34,250 to ₩28,750. Share price fell 9.8% to ₩17,740 over the past week.Price Target Changed • Nov 13Price target decreased by 13% to ₩39,286Down from ₩45,143, the current price target is an average from 7 analysts. New target price is 125% above last closing price of ₩17,480. Stock is down 43% over the past year. The company is forecast to post earnings per share of ₩1,585 for next year compared to ₩1,582 last year.Valuation Update With 7 Day Price Move • Nov 12Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₩17,810, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 10x in the Personal Products industry in South Korea. Total loss to shareholders of 11% over the past three years.Valuation Update With 7 Day Price Move • Oct 28Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩21,850, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total loss to shareholders of 1.7% over the past three years.분석 기사 • Oct 08CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Price Is Out Of Tune With EarningsWith a median price-to-earnings (or "P/E") ratio of close to 12x in Korea, you could be forgiven for feeling...분석 기사 • Jun 26If EPS Growth Is Important To You, CLIO CosmeticsLtd (KOSDAQ:237880) Presents An OpportunityInvestors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...New Risk • Jun 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.분석 기사 • May 25What CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) 27% Share Price Gain Is Not Telling YouDespite an already strong run, CLIO Cosmetics Co.,Ltd ( KOSDAQ:237880 ) shares have been powering on, with a gain of...분석 기사 • May 21The Strong Earnings Posted By CLIO CosmeticsLtd (KOSDAQ:237880) Are A Good Indication Of The Strength Of The BusinessEven though CLIO Cosmetics Co.,Ltd's ( KOSDAQ:237880 ) recent earnings release was robust, the market didn't seem to...분석 기사 • Apr 24We Like These Underlying Return On Capital Trends At CLIO CosmeticsLtd (KOSDAQ:237880)Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...분석 기사 • Apr 01Some Shareholders Feeling Restless Over CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) P/E RatioWith a price-to-earnings (or "P/E") ratio of 19.9x CLIO Cosmetics Co.,Ltd ( KOSDAQ:237880 ) may be sending very bearish...Price Target Changed • Feb 19Price target increased by 7.2% to ₩42,000Up from ₩39,167, the current price target is an average from 6 analysts. New target price is 38% above last closing price of ₩30,400. Stock is up 74% over the past year. The company is forecast to post earnings per share of ₩1,466 for next year compared to ₩584 last year.공시 • Feb 13CLIO Cosmetics Co.,Ltd to Report Fiscal Year 2023 Results on Feb 15, 2024CLIO Cosmetics Co.,Ltd announced that they will report fiscal year 2023 results on Feb 15, 2024Upcoming Dividend • Dec 20Upcoming dividend of ₩200 per share at 0.6% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 10 April 2024. Payout ratio is a comfortable 14% and this is well supported by cash flows. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.2%).Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩556 (vs ₩187 in 3Q 2022)Third quarter 2023 results: EPS: ₩556 (up from ₩187 in 3Q 2022). Revenue: ₩84.8b (up 25% from 3Q 2022). Net income: ₩9.89b (up 206% from 3Q 2022). Profit margin: 12% (up from 4.8% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.Major Estimate Revision • Nov 12Consensus EPS estimates increase by 23%The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate increased from ₩1,207 to ₩1,490. Revenue forecast steady at ₩331.2m. Net income forecast to grow 65% next year vs 78% growth forecast for Personal Products industry in South Korea. Consensus price target up from ₩31,000 to ₩34,800. Share price rose 15% to ₩30,850 over the past week.Valuation Update With 7 Day Price Move • Nov 09Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩32,200, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 17x in the Personal Products industry in South Korea. Total returns to shareholders of 88% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩41,682 per share.Price Target Changed • Oct 19Price target increased by 8.1% to ₩31,000Up from ₩28,667, the current price target is an average from 5 analysts. New target price is 11% above last closing price of ₩28,000. Stock is up 111% over the past year. The company is forecast to post earnings per share of ₩1,207 for next year compared to ₩584 last year.Valuation Update With 7 Day Price Move • Sep 08Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₩25,950, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Personal Products industry in South Korea. Total returns to shareholders of 50% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩39,744 per share.New Risk • Aug 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Valuation Update With 7 Day Price Move • Aug 10Investor sentiment improves as stock rises 29%After last week's 29% share price gain to ₩23,400, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 17x in the Personal Products industry in South Korea. Total returns to shareholders of 30% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩39,866 per share.Price Target Changed • May 17Price target increased by 10% to ₩29,000Up from ₩26,333, the current price target is provided by 1 analyst. New target price is 29% above last closing price of ₩22,550. Stock is up 28% over the past year. The company is forecast to post earnings per share of ₩651 for next year compared to ₩584 last year.Upcoming Dividend • Dec 21Upcoming dividend of ₩150 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 20 April 2023. Payout ratio is a comfortable 49% and this is well supported by cash flows. Trailing yield: 1.0%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (1.3%).Valuation Update With 7 Day Price Move • Dec 05Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩15,700, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total loss to shareholders of 17% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩28,987 per share.Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • Nov 15CLIO Cosmetics Co.,Ltd to Report Q3, 2022 Results on Nov 16, 2022CLIO Cosmetics Co.,Ltd announced that they will report Q3, 2022 results on Nov 16, 2022Valuation Update With 7 Day Price Move • Sep 20Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩16,100, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 16x in the Personal Products industry in South Korea. Total loss to shareholders of 14% over the past three years.Price Target Changed • Jun 22Price target decreased to ₩28,000Down from ₩30,333, the current price target is an average from 3 analysts. New target price is 95% above last closing price of ₩14,350. Stock is down 42% over the past year. The company is forecast to post earnings per share of ₩749 for next year compared to ₩552 last year.Major Estimate Revision • May 20Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from ₩824 to ₩737 per share. Revenue forecast steady at ₩262.5m. Net income forecast to grow 40% next year vs 22% growth forecast for Personal Products industry in South Korea. Consensus price target of ₩30,800 unchanged from last update. Share price fell 5.8% to ₩17,200 over the past week.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₩19,450, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total returns to shareholders of 53% over the past three years.Upcoming Dividend • Dec 22Upcoming dividend of ₩100.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 20 April 2022. Payout ratio is a comfortable 16% and this is well supported by cash flows. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (0.8%).Price Target Changed • Jun 01Price target increased to ₩29,000Up from ₩26,800, the current price target is an average from 5 analysts. New target price is 5.6% above last closing price of ₩27,450. Stock is up 28% over the past year.Valuation Update With 7 Day Price Move • May 31Investor sentiment improved over the past weekAfter last week's 24% share price gain to ₩27,500, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 19x in the Personal Products industry in South Korea. Total returns to shareholders of 6.7% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩24,905 per share.Price Target Changed • May 20Price target increased to ₩26,800Up from ₩25,000, the current price target is an average from 5 analysts. New target price is 17% above last closing price of ₩22,850. Stock is up 2.5% over the past year.분석 기사 • Apr 13Is CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) 1.0% Dividend Worth Your Time?Could CLIO Cosmetics Co.,Ltd ( KOSDAQ:237880 ) be an attractive dividend share to own for the long haul? Investors are...분석 기사 • Mar 30When Should You Buy CLIO Cosmetics Co.,Ltd (KOSDAQ:237880)?CLIO Cosmetics Co.,Ltd ( KOSDAQ:237880 ), is not the largest company out there, but it received a lot of attention from...Reported Earnings • Mar 21Full year 2020 earnings released: EPS ₩576 (vs ₩177 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: ₩218.2b (down 13% from FY 2019). Net income: ₩9.59b (up 226% from FY 2019). Profit margin: 4.4% (up from 1.2% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.분석 기사 • Mar 16Here's Why CLIO CosmeticsLtd (KOSDAQ:237880) Can Manage Its Debt ResponsiblySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...분석 기사 • Mar 02Does This Valuation Of CLIO Cosmetics Co.,Ltd (KOSDAQ:237880) Imply Investors Are Overpaying?Today we will run through one way of estimating the intrinsic value of CLIO Cosmetics Co.,Ltd ( KOSDAQ:237880 ) by...공시 • Feb 22CLIO Cosmetics Co.,Ltd, Annual General Meeting, Mar 26, 2021CLIO Cosmetics Co.,Ltd, Annual General Meeting, Mar 26, 2021, at 09:00 Korea Standard Time.분석 기사 • Feb 17CLIO CosmeticsLtd's (KOSDAQ:237880) Shareholders Are Down 47% On Their SharesWhile not a mind-blowing move, it is good to see that the CLIO Cosmetics Co.,Ltd ( KOSDAQ:237880 ) share price has...분석 기사 • Feb 02Does CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Weak Fundamentals Mean That The Market Could Correct Its Share Price?Most readers would already be aware that CLIO CosmeticsLtd's (KOSDAQ:237880) stock increased significantly by 22% over...Is New 90 Day High Low • Jan 22New 90-day high: ₩21,900The company is up 37% from its price of ₩16,000 on 23 October 2020. The South Korean market is up 32% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩11,375 per share.분석 기사 • Jan 18What Type Of Shareholders Make Up CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Share Registry?Every investor in CLIO Cosmetics Co.,Ltd ( KOSDAQ:237880 ) should be aware of the most powerful shareholder groups...Major Estimate Revision • Jan 16Analysts lower EPS estimates to ₩550The 2020 consensus revenue estimate was lowered from ₩241.6m to ₩226.5m. Earning per share (EPS) estimate was also lowered from ₩634 to ₩550 for the same period. Net income is expected to grow by 197% next year compared to 51% growth forecast for the Personal Products industry in South Korea. The consensus price target increased from ₩25,000 to ₩25,500. Share price is up 11% to ₩21,200 over the past week.분석 기사 • Jan 05Are Dividend Investors Making A Mistake With CLIO Cosmetics Co.,Ltd (KOSDAQ:237880)?Dividend paying stocks like CLIO Cosmetics Co.,Ltd ( KOSDAQ:237880 ) tend to be popular with investors, and for good...Is New 90 Day High Low • Jan 05New 90-day high: ₩18,900The company is up 15% from its price of ₩16,400 on 07 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Personal Products industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩4,974 per share.분석 기사 • Dec 23Should You Think About Buying CLIO Cosmetics Co.,Ltd (KOSDAQ:237880) Now?While CLIO Cosmetics Co.,Ltd ( KOSDAQ:237880 ) might not be the most widely known stock at the moment, it saw...Upcoming Dividend • Dec 22Upcoming Dividend of ₩220 Per ShareWill be paid on the 21st of April to those who are registered shareholders by the 29th of December. The trailing yield of 1.3% is below the top quartile of South Korean dividend payers (2.6%), but it is higher than industry peers (0.6%).분석 기사 • Dec 08Are CLIO CosmeticsLtd's (KOSDAQ:237880) Statutory Earnings A Good Reflection Of Its Earnings Potential?Statistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. That said, the...분석 기사 • Nov 25CLIO CosmeticsLtd (KOSDAQ:237880) Seems To Use Debt Rather SparinglyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Is New 90 Day High Low • Oct 27New 90-day low: ₩15,600The company is down 12% from its price of ₩17,700 on 29 July 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩12,051 per share.Is New 90 Day High Low • Sep 24New 90-day low: ₩15,750The company is down 11% from its price of ₩17,650 on 26 June 2020. The South Korean market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩12,112 per share.이익 및 매출 성장 예측KOSDAQ:A237880 - 애널리스트 향후 추정치 및 과거 재무 데이터 (KRW Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/2028354,00023,50029,00029,500212/31/2027343,00021,00031,00029,500212/31/2026328,00018,5008,00021,00023/31/2026324,91517,62421,98222,528N/A12/31/2025328,90313,56312,47313,245N/A9/30/2025326,53112,6823,7304,700N/A6/30/2025330,27413,27515,76316,578N/A3/31/2025340,72620,44315,66416,488N/A12/31/2024351,36627,86516,58717,306N/A9/30/2024362,81132,19935,30135,776N/A6/30/2024360,07035,97032,00032,625N/A3/31/2024348,48932,16044,48045,288N/A12/31/2023330,58427,69634,85635,725N/A9/30/2023313,26424,21228,84929,842N/A6/30/2023296,39417,55628,77329,877N/A3/31/2023281,58815,03621,33022,356N/A12/31/2022272,45510,129-1,41728,205N/A9/30/2022259,4885,3094,23336,732N/A6/30/2022250,9039,67335932,940N/A3/31/2022240,7677,81515,09747,579N/A12/31/2021232,7449,26748,29851,952N/A9/30/2021223,55510,19537,28838,046N/A6/30/2021214,7855,89337,63038,588N/A3/31/2021208,3667,95011,85712,987N/A12/31/2020218,2169,58510,52411,877N/A9/30/2020237,5054,63014,45418,066N/A6/30/2020249,1217,43614,09219,257N/A3/31/2020260,3375,64347,15354,508N/A12/31/2019250,3832,942N/A39,819N/A9/30/2019230,1275,482N/A73,667N/A6/30/2019214,248517N/A66,775N/A3/31/2019199,734119N/A39,491N/A12/31/2018187,378996N/A62,214N/A9/30/2018186,9561,538N/A1,843N/A6/30/2018187,4424,151N/A5,524N/A3/31/2018181,8515,625N/A1,336N/A12/31/2017193,6807,933N/A-22,989N/A9/30/2017197,94313,777N/A-4,928N/A6/30/2017201,32415,634N/A-1,244N/A3/31/2017205,10716,339N/A-132N/A12/31/2016193,59020,812N/A4,757N/A9/30/2016177,60225,362N/A22,878N/A6/30/2016164,51027,612N/A33,408N/A3/31/2016136,41025,537N/A43,975N/A12/31/2015107,07717,694N/A39,820N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: A237880 의 연간 예상 수익 증가율(10.9%)이 saving rate(3.1%)보다 높습니다.수익 vs 시장: A237880 의 연간 수익(10.9%)이 KR 시장(33%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: A237880 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: A237880 의 수익(연간 3.3%)이 KR 시장(연간 16.3%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: A237880 의 수익(연간 3.3%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: A237880의 자본 수익률은 3년 후 8%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YHousehold 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/12 23:22종가2026/06/12 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스CLIO Cosmetics Co.,Ltd는 9명의 분석가가 다루고 있습니다. 이 중 3명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Hyungwook ChoiDaiwa Securities Co. Ltd.null nullDBS Bank LtdSunhwa LeeEugene Investment & Securities Co Ltd.6명의 분석가 더 보기
Major Estimate Revision • Jun 08Consensus EPS estimates increase by 13%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from ₩322.0m to ₩328.0m. EPS estimate increased from ₩920 to ₩1,040 per share. Net income forecast to grow 8.5% next year vs 38% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩13,000 to ₩12,000. Share price fell 7.8% to ₩10,060 over the past week.
Price Target Changed • May 29Price target decreased by 7.1% to ₩13,000Down from ₩14,000, the current price target is an average from 2 analysts. New target price is 13% above last closing price of ₩11,540. Stock is down 27% over the past year. The company is forecast to post earnings per share of ₩920 for next year compared to ₩774 last year.
Major Estimate Revision • May 17Consensus EPS estimates fall by 19%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩384.0m to ₩359.0m. EPS estimate also fell from ₩1,826 per share to ₩1,486 per share. Net income forecast to shrink 4.9% next year vs 34% growth forecast for Personal Products industry in South Korea . Consensus price target down from ₩28,750 to ₩23,800. Share price fell 19% to ₩15,450 over the past week.
Major Estimate Revision • Feb 26Consensus EPS estimates fall by 16%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩417.1m to ₩384.0m. EPS estimate also fell from ₩2,165 per share to ₩1,826 per share. Net income forecast to shrink 0.2% next year vs 32% growth forecast for Personal Products industry in South Korea . Consensus price target down from ₩34,250 to ₩28,750. Share price fell 9.8% to ₩17,740 over the past week.
Price Target Changed • Nov 13Price target decreased by 13% to ₩39,286Down from ₩45,143, the current price target is an average from 7 analysts. New target price is 125% above last closing price of ₩17,480. Stock is down 43% over the past year. The company is forecast to post earnings per share of ₩1,585 for next year compared to ₩1,582 last year.
Price Target Changed • Feb 19Price target increased by 7.2% to ₩42,000Up from ₩39,167, the current price target is an average from 6 analysts. New target price is 38% above last closing price of ₩30,400. Stock is up 74% over the past year. The company is forecast to post earnings per share of ₩1,466 for next year compared to ₩584 last year.
Major Estimate Revision • Jun 08Consensus EPS estimates increase by 13%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from ₩322.0m to ₩328.0m. EPS estimate increased from ₩920 to ₩1,040 per share. Net income forecast to grow 8.5% next year vs 38% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩13,000 to ₩12,000. Share price fell 7.8% to ₩10,060 over the past week.
Price Target Changed • May 29Price target decreased by 7.1% to ₩13,000Down from ₩14,000, the current price target is an average from 2 analysts. New target price is 13% above last closing price of ₩11,540. Stock is down 27% over the past year. The company is forecast to post earnings per share of ₩920 for next year compared to ₩774 last year.
공시 • May 07CLIO Cosmetics Co.,Ltd to Report Q1, 2026 Results on May 11, 2026CLIO Cosmetics Co.,Ltd announced that they will report Q1, 2026 results on May 11, 2026
분석 기사 • Apr 03CLIO CosmeticsLtd's (KOSDAQ:237880) Conservative Accounting Might Explain Soft EarningsShareholders appeared unconcerned with CLIO Cosmetics Co.,Ltd's ( KOSDAQ:237880 ) lackluster earnings report last week...
공시 • Mar 14CLIO Cosmetics Co.,Ltd, Annual General Meeting, Mar 31, 2026CLIO Cosmetics Co.,Ltd, Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 66, wangsimni-ro, seongdong-gu, seoul South Korea
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩11,170, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total loss to shareholders of 38% over the past three years.
공시 • Feb 13CLIO Cosmetics Co.,Ltd to Report Fiscal Year 2025 Results on Feb 13, 2026CLIO Cosmetics Co.,Ltd announced that they will report fiscal year 2025 results on Feb 13, 2026
공시 • Jan 07CLIO Cosmetics Co.,Ltd announced that it has received KRW 8.42292238 billion in funding from NH Investment & Securities Co., Ltd., KB Securities Co., Ltd., Mirae Asset Securities Co., Ltd., Samsung Securities Co.,Ltd., Synergy IB Investment Co., Ltd., Synergy-Premier Mezzanine Blind No. 1 New Technology Business Investment Fund and other investorsOn January 7, 2026, CLIO Cosmetics Co.,Ltd closed the transaction.
공시 • Aug 09CLIO Cosmetics Co.,Ltd to Report First Half, 2025 Results on Aug 13, 2025CLIO Cosmetics Co.,Ltd announced that they will report first half, 2025 results on Aug 13, 2025
New Risk • May 23New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.0% Last year net profit margin: 9.2% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (6.0% net profit margin).
Major Estimate Revision • May 17Consensus EPS estimates fall by 19%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩384.0m to ₩359.0m. EPS estimate also fell from ₩1,826 per share to ₩1,486 per share. Net income forecast to shrink 4.9% next year vs 34% growth forecast for Personal Products industry in South Korea . Consensus price target down from ₩28,750 to ₩23,800. Share price fell 19% to ₩15,450 over the past week.
Valuation Update With 7 Day Price Move • May 15Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₩16,080, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 13x in the Personal Products industry in South Korea. Total loss to shareholders of 1.6% over the past three years.
분석 기사 • Apr 10Pinning Down CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) P/E Is Difficult Right NowWith a median price-to-earnings (or "P/E") ratio of close to 11x in Korea, you could be forgiven for feeling...
공시 • Mar 12CLIO Cosmetics Co.,Ltd, Annual General Meeting, Mar 28, 2025CLIO Cosmetics Co.,Ltd, Annual General Meeting, Mar 28, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 66, wangsimni-ro, seongdong-gu, seoul South Korea
분석 기사 • Mar 11We Like These Underlying Return On Capital Trends At CLIO CosmeticsLtd (KOSDAQ:237880)Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...
Valuation Update With 7 Day Price Move • Mar 11Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₩21,100, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total returns to shareholders of 1.6% over the past three years.
Major Estimate Revision • Feb 26Consensus EPS estimates fall by 16%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩417.1m to ₩384.0m. EPS estimate also fell from ₩2,165 per share to ₩1,826 per share. Net income forecast to shrink 0.2% next year vs 32% growth forecast for Personal Products industry in South Korea . Consensus price target down from ₩34,250 to ₩28,750. Share price fell 9.8% to ₩17,740 over the past week.
Price Target Changed • Nov 13Price target decreased by 13% to ₩39,286Down from ₩45,143, the current price target is an average from 7 analysts. New target price is 125% above last closing price of ₩17,480. Stock is down 43% over the past year. The company is forecast to post earnings per share of ₩1,585 for next year compared to ₩1,582 last year.
Valuation Update With 7 Day Price Move • Nov 12Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₩17,810, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 10x in the Personal Products industry in South Korea. Total loss to shareholders of 11% over the past three years.
Valuation Update With 7 Day Price Move • Oct 28Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩21,850, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total loss to shareholders of 1.7% over the past three years.
분석 기사 • Oct 08CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Price Is Out Of Tune With EarningsWith a median price-to-earnings (or "P/E") ratio of close to 12x in Korea, you could be forgiven for feeling...
분석 기사 • Jun 26If EPS Growth Is Important To You, CLIO CosmeticsLtd (KOSDAQ:237880) Presents An OpportunityInvestors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
New Risk • Jun 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
분석 기사 • May 25What CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) 27% Share Price Gain Is Not Telling YouDespite an already strong run, CLIO Cosmetics Co.,Ltd ( KOSDAQ:237880 ) shares have been powering on, with a gain of...
분석 기사 • May 21The Strong Earnings Posted By CLIO CosmeticsLtd (KOSDAQ:237880) Are A Good Indication Of The Strength Of The BusinessEven though CLIO Cosmetics Co.,Ltd's ( KOSDAQ:237880 ) recent earnings release was robust, the market didn't seem to...
분석 기사 • Apr 24We Like These Underlying Return On Capital Trends At CLIO CosmeticsLtd (KOSDAQ:237880)Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
분석 기사 • Apr 01Some Shareholders Feeling Restless Over CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) P/E RatioWith a price-to-earnings (or "P/E") ratio of 19.9x CLIO Cosmetics Co.,Ltd ( KOSDAQ:237880 ) may be sending very bearish...
Price Target Changed • Feb 19Price target increased by 7.2% to ₩42,000Up from ₩39,167, the current price target is an average from 6 analysts. New target price is 38% above last closing price of ₩30,400. Stock is up 74% over the past year. The company is forecast to post earnings per share of ₩1,466 for next year compared to ₩584 last year.
공시 • Feb 13CLIO Cosmetics Co.,Ltd to Report Fiscal Year 2023 Results on Feb 15, 2024CLIO Cosmetics Co.,Ltd announced that they will report fiscal year 2023 results on Feb 15, 2024
Upcoming Dividend • Dec 20Upcoming dividend of ₩200 per share at 0.6% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 10 April 2024. Payout ratio is a comfortable 14% and this is well supported by cash flows. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.2%).
Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩556 (vs ₩187 in 3Q 2022)Third quarter 2023 results: EPS: ₩556 (up from ₩187 in 3Q 2022). Revenue: ₩84.8b (up 25% from 3Q 2022). Net income: ₩9.89b (up 206% from 3Q 2022). Profit margin: 12% (up from 4.8% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.
Major Estimate Revision • Nov 12Consensus EPS estimates increase by 23%The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate increased from ₩1,207 to ₩1,490. Revenue forecast steady at ₩331.2m. Net income forecast to grow 65% next year vs 78% growth forecast for Personal Products industry in South Korea. Consensus price target up from ₩31,000 to ₩34,800. Share price rose 15% to ₩30,850 over the past week.
Valuation Update With 7 Day Price Move • Nov 09Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩32,200, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 17x in the Personal Products industry in South Korea. Total returns to shareholders of 88% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩41,682 per share.
Price Target Changed • Oct 19Price target increased by 8.1% to ₩31,000Up from ₩28,667, the current price target is an average from 5 analysts. New target price is 11% above last closing price of ₩28,000. Stock is up 111% over the past year. The company is forecast to post earnings per share of ₩1,207 for next year compared to ₩584 last year.
Valuation Update With 7 Day Price Move • Sep 08Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₩25,950, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Personal Products industry in South Korea. Total returns to shareholders of 50% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩39,744 per share.
New Risk • Aug 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Valuation Update With 7 Day Price Move • Aug 10Investor sentiment improves as stock rises 29%After last week's 29% share price gain to ₩23,400, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 17x in the Personal Products industry in South Korea. Total returns to shareholders of 30% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩39,866 per share.
Price Target Changed • May 17Price target increased by 10% to ₩29,000Up from ₩26,333, the current price target is provided by 1 analyst. New target price is 29% above last closing price of ₩22,550. Stock is up 28% over the past year. The company is forecast to post earnings per share of ₩651 for next year compared to ₩584 last year.
Upcoming Dividend • Dec 21Upcoming dividend of ₩150 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 20 April 2023. Payout ratio is a comfortable 49% and this is well supported by cash flows. Trailing yield: 1.0%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (1.3%).
Valuation Update With 7 Day Price Move • Dec 05Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩15,700, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total loss to shareholders of 17% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩28,987 per share.
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • Nov 15CLIO Cosmetics Co.,Ltd to Report Q3, 2022 Results on Nov 16, 2022CLIO Cosmetics Co.,Ltd announced that they will report Q3, 2022 results on Nov 16, 2022
Valuation Update With 7 Day Price Move • Sep 20Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩16,100, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 16x in the Personal Products industry in South Korea. Total loss to shareholders of 14% over the past three years.
Price Target Changed • Jun 22Price target decreased to ₩28,000Down from ₩30,333, the current price target is an average from 3 analysts. New target price is 95% above last closing price of ₩14,350. Stock is down 42% over the past year. The company is forecast to post earnings per share of ₩749 for next year compared to ₩552 last year.
Major Estimate Revision • May 20Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from ₩824 to ₩737 per share. Revenue forecast steady at ₩262.5m. Net income forecast to grow 40% next year vs 22% growth forecast for Personal Products industry in South Korea. Consensus price target of ₩30,800 unchanged from last update. Share price fell 5.8% to ₩17,200 over the past week.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₩19,450, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total returns to shareholders of 53% over the past three years.
Upcoming Dividend • Dec 22Upcoming dividend of ₩100.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 20 April 2022. Payout ratio is a comfortable 16% and this is well supported by cash flows. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (0.8%).
Price Target Changed • Jun 01Price target increased to ₩29,000Up from ₩26,800, the current price target is an average from 5 analysts. New target price is 5.6% above last closing price of ₩27,450. Stock is up 28% over the past year.
Valuation Update With 7 Day Price Move • May 31Investor sentiment improved over the past weekAfter last week's 24% share price gain to ₩27,500, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 19x in the Personal Products industry in South Korea. Total returns to shareholders of 6.7% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩24,905 per share.
Price Target Changed • May 20Price target increased to ₩26,800Up from ₩25,000, the current price target is an average from 5 analysts. New target price is 17% above last closing price of ₩22,850. Stock is up 2.5% over the past year.
분석 기사 • Apr 13Is CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) 1.0% Dividend Worth Your Time?Could CLIO Cosmetics Co.,Ltd ( KOSDAQ:237880 ) be an attractive dividend share to own for the long haul? Investors are...
분석 기사 • Mar 30When Should You Buy CLIO Cosmetics Co.,Ltd (KOSDAQ:237880)?CLIO Cosmetics Co.,Ltd ( KOSDAQ:237880 ), is not the largest company out there, but it received a lot of attention from...
Reported Earnings • Mar 21Full year 2020 earnings released: EPS ₩576 (vs ₩177 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: ₩218.2b (down 13% from FY 2019). Net income: ₩9.59b (up 226% from FY 2019). Profit margin: 4.4% (up from 1.2% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.
분석 기사 • Mar 16Here's Why CLIO CosmeticsLtd (KOSDAQ:237880) Can Manage Its Debt ResponsiblySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
분석 기사 • Mar 02Does This Valuation Of CLIO Cosmetics Co.,Ltd (KOSDAQ:237880) Imply Investors Are Overpaying?Today we will run through one way of estimating the intrinsic value of CLIO Cosmetics Co.,Ltd ( KOSDAQ:237880 ) by...
공시 • Feb 22CLIO Cosmetics Co.,Ltd, Annual General Meeting, Mar 26, 2021CLIO Cosmetics Co.,Ltd, Annual General Meeting, Mar 26, 2021, at 09:00 Korea Standard Time.
분석 기사 • Feb 17CLIO CosmeticsLtd's (KOSDAQ:237880) Shareholders Are Down 47% On Their SharesWhile not a mind-blowing move, it is good to see that the CLIO Cosmetics Co.,Ltd ( KOSDAQ:237880 ) share price has...
분석 기사 • Feb 02Does CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Weak Fundamentals Mean That The Market Could Correct Its Share Price?Most readers would already be aware that CLIO CosmeticsLtd's (KOSDAQ:237880) stock increased significantly by 22% over...
Is New 90 Day High Low • Jan 22New 90-day high: ₩21,900The company is up 37% from its price of ₩16,000 on 23 October 2020. The South Korean market is up 32% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩11,375 per share.
분석 기사 • Jan 18What Type Of Shareholders Make Up CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Share Registry?Every investor in CLIO Cosmetics Co.,Ltd ( KOSDAQ:237880 ) should be aware of the most powerful shareholder groups...
Major Estimate Revision • Jan 16Analysts lower EPS estimates to ₩550The 2020 consensus revenue estimate was lowered from ₩241.6m to ₩226.5m. Earning per share (EPS) estimate was also lowered from ₩634 to ₩550 for the same period. Net income is expected to grow by 197% next year compared to 51% growth forecast for the Personal Products industry in South Korea. The consensus price target increased from ₩25,000 to ₩25,500. Share price is up 11% to ₩21,200 over the past week.
분석 기사 • Jan 05Are Dividend Investors Making A Mistake With CLIO Cosmetics Co.,Ltd (KOSDAQ:237880)?Dividend paying stocks like CLIO Cosmetics Co.,Ltd ( KOSDAQ:237880 ) tend to be popular with investors, and for good...
Is New 90 Day High Low • Jan 05New 90-day high: ₩18,900The company is up 15% from its price of ₩16,400 on 07 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Personal Products industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩4,974 per share.
분석 기사 • Dec 23Should You Think About Buying CLIO Cosmetics Co.,Ltd (KOSDAQ:237880) Now?While CLIO Cosmetics Co.,Ltd ( KOSDAQ:237880 ) might not be the most widely known stock at the moment, it saw...
Upcoming Dividend • Dec 22Upcoming Dividend of ₩220 Per ShareWill be paid on the 21st of April to those who are registered shareholders by the 29th of December. The trailing yield of 1.3% is below the top quartile of South Korean dividend payers (2.6%), but it is higher than industry peers (0.6%).
분석 기사 • Dec 08Are CLIO CosmeticsLtd's (KOSDAQ:237880) Statutory Earnings A Good Reflection Of Its Earnings Potential?Statistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. That said, the...
분석 기사 • Nov 25CLIO CosmeticsLtd (KOSDAQ:237880) Seems To Use Debt Rather SparinglyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Is New 90 Day High Low • Oct 27New 90-day low: ₩15,600The company is down 12% from its price of ₩17,700 on 29 July 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩12,051 per share.
Is New 90 Day High Low • Sep 24New 90-day low: ₩15,750The company is down 11% from its price of ₩17,650 on 26 June 2020. The South Korean market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩12,112 per share.